Skip to main content
. 2015 Sep 4;10(9):e0136616. doi: 10.1371/journal.pone.0136616

Fig 4. Overall survival (OS) and recurrence-free survival (RFS) curves for the patients with clinical stage IA lung adenocarcinoma with ground-glass components who underwent surgical resection in group1, group2 and group 3.

Fig 4

Group 1 = clinical high-risk group, group 2 = clinical moderate-risk group, group 3 = clinical low-risk group.